RadioRx
A company developing X-nitro compounds for micro treatments for cancer, inflamation, cardiovascular and autoimmune diseases
1
Funding Rounds
$20.5m
Money raised
Overview
A company developing X-nitro compounds for micro treatments for cancer, inflamation, cardiovascular and autoimmune diseases
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company RadioRx has raised a total of $20.45m in funding over 1 rounds.
Key Insights:
- RadioRx funding round, April 2013: $20.45m
RadioRx funding round, April 2013
$20.45m
Industries
RadioRx is active in the following industries: